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Catch-up growth early in life (after fetal, neonatal or infantile growth retardation) is a major risk
factor for later obesity, type-2 diabetes and cardiovascular diseases. These risks are generally
interpreted alongside teleological arguments that environmental exposures which hinder growth
early in life lead to programming of ‘thrifty mechanisms’ that are adaptive during the period of
limited nutrient supply (or growth constraint), but which increase risks for diseases during
improved nutrition and catch-up growth later in life. This paper addresses this notion of ‘thrifty
mechanisms’ in the light of evidence that catch-up growth is characterized by a disproportion-
ately higher rate of fat gain relative to lean tissue gain, and that such preferential catch-up fat is in
part driven by energy conservation mechanisms operating via suppressed thermogenesis. It pro-
vides a molecular-physiological framework which integrates emerging insights into mechanisms
by which this thrifty ‘catch-up fat’ phenotype cross-links with insulin and leptin resistance.
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CATCH-UP GROWTH TRAJECTORIES TO OBESITYAND METABOLIC
SYNDROME
Obesity has reached epidemic proportions worldwide and is the driving force behind
an equally alarming explosion of type-2 diabetes and cardiovascular diseases. Even
more alarming is the fact that this rise in the global prevalence of obesity is affecting
children, and increasingly preschool-age children. According to the International
Obesity Task Force, at least 155 million school-age children worldwide are currently
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overweight, with 30–45 million classiﬁed as obese. In countries of the European Union
alone, the number of children affected by overweight and obesity is now rising at
nearly 400,000 a year, and already one in four children is overweight. These grim ﬁg-
ures forecast a deepening crisis in public health as infants and children are being ex-
posed to the potentially damaging metabolic and cardiovascular insults of excess fat
gain during critical periods of growth and development. It is therefore not surprising
that the limelight of research into understanding the pathogenesis of obesity and in
developing effective strategies for its prevention has now shifted towards the identiﬁ-
cation of environmental factors, events and growth patterns that very early in life pre-
dispose to later obesity and risks for the insulin resistance (metabolic) syndrome.1 In
this context, catch-up growth – which has long been viewed as a physiological adapta-
tion that re-establishes the genetically programmed growth trajectory – has emerged
as a major risk factor for obesity and chronic metabolic diseases.
Indeed, the analyses of several large epidemiological databases from several coun-
tries have indicated that people who had low birth weight (a marker of fetal growth
constraint) or who showed faltered growth during infancy and childhood but who sub-
sequently showed catch-up growth, have higher susceptibility for obesity, type-2
diabetes and/or cardiovascular diseases later in life.2–7 In the most recent and most
detailed retrospective longitudinal study from Finland, it was shown that men and
women who were small at birth and thin during infancy and who subsequently showed
catch-up growth had higher risks of coronary events associated with insulin resis-
tance.7 These higher risks were also found to be more strongly related to the tempo
of childhood gain in body mass index (BMI) than to the BMI attained at any particular
age, thereby underscoring the fundamental importance of the dynamic aspects of
catch-up growth per se on later insulin resistance and cardiovascular risks. There is
also evidence that early postnatal catch-up growth in those born preterm also
increases the risk for insulin resistance later in life. In particular, children and adoles-
cents who showed neonatal catch-up growth after being born prematurely, irrespec-
tive of whether they were appropriate for gestational age (AGA) or small for
gestational age (SGA), have reduced insulin sensitivity and increased circulating insulin
levels.8,9 Furthermore, in a prospective long-term follow-up into young adulthood of
men and women born very preterm, catch-up growth during early infancy was a pre-
dictor of adult fat accumulation10 as well as central fat distribution and higher insulin
levels at 19 years of age.11 Finally, it should be emphasized that these risks for later
obesity and insulin-related complications associated with earlier catch-up growth
are not conﬁned to children born preterm or to the SGA population, but have also
been reported in children born AGA but who were nonetheless relatively light and
short at birth, possibly because of more subtle intrauterine growth constraint.5 The
fundamental question that arises therefore is how (and why) does catch-up growth
– which has long been viewed an essential feature of recovery from the deleterious
effects of poor growth on development and health – confer such predisposition to
obesity and insulin-related diseases?
DEVELOPMENTAL PROGRAMMING AND THRIFTY PHENOTYPES
The most common explanations are embodied in theories of metabolic ‘programming’
or ‘imprinting’, which postulate that food deprivation, malnutrition or other insults
during critical periods of growth and development can lead to lasting alterations in
structures and functions of tissues, and in the resetting of neuroendocrine systems
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involved in energy metabolism and weight regulation.12–15 For example, the hypotha-
lamic–pituitary–adrenal activity, as well as the sympathoadrenal system, can be altered
permanently by variations in glucocorticoid exposure due e.g. to maternal stress and
maternal protein deﬁciency during pregnancy and lactation, all of which have been
shown to lead to obesity and metabolic syndrome in animal models.12–15
A critical role for perturbations in leptin production on brain development has also
been advocated in fetal and neonatal programming for obesity and the metabolic syn-
drome. Such a neurotrophic role for leptin early in life is strongly supported by the
observations that leptin-deﬁcient mice have reduced neural projections from the arcu-
ate nucleus to a number of other hypothalamic nuclei involved in energy homeostasis,
and that these neuroanatomical defects can be reversed by exogenous leptin adminis-
tration in the neonatal period but not in adult mice.16 Of particular relevance to
nutritional programming of energy balance are the ﬁndings that alterations in maternal
and neonatal nutrition can alter the proﬁle of the postnatal leptin surge and hypotha-
lamic development.17 Indeed, intrauterine under-nutrition in mice resulted in offspring
which exhibited a premature leptin surge, and subsequently showed an increased sus-
ceptibility to obesity when weaned on a high-fat diet. Thus it appears that the timing of
the postnatal leptin surge plays a critical role in the development of hypothalamic cir-
cuits that inﬂuence food intake and energy expenditure, and that this process can be
greatly affected by early nutrition.
The importance of leptin in developmental programming has been further strength-
ened by studies in rat models of maternal under-nutrition or protein restriction which
have indicated that leptin administration in pregnancy and lactation protect the off-
spring from later obesity and insulin resistance that would otherwise develop on
a high-fat diet.18,19 The clinical relevance of these observations, like the ontogeny of
early-life leptin levels in humans, has yet to be established, particularly in the context
that leptin is present in breast milk20 but not in infant formulae, and that breast-feeding
has been found to lower the risk for obesity compared with formula feeding.21,22 None-
theless, the ﬁndings that low leptin levels in cord blood closely reﬂect low adipose mass
at birth, and strongly predict high rates of weight gain during infancy23, are consistent
with a role for major perturbations in leptin production in developmental program-
ming. Furthermore, the observations of high serum leptin concentrations during
catch-up growth in infants born SGA 24 or in children recovering from mild protein-
energy malnutrition25 raise the possibility that hyperleptinaemia and leptin resistance
may play a role in the pathophysiology of catch-up growth.
Hyperinsulinemia during catch-up growth early in life, by inducing permanent
changes in hypothalamic morphology and in the functional state of the sympathoadre-
nal system, has also been implicated in the programming of obesity later in life.13 A
higher plasma insulin response to a glucose load has long been demonstrated during
catch-up growth in infants born SGA26, and more recently strong associations have
been described in many countries between thinness during early infancy and elevated
plasma insulin during catch-up growth later in childhood.27,28 These ﬁndings, together
with prospective studies from Chile29 indicating that reduced insulin sensitivity could
be related to catch-up growth in SGA infants as early as at 1 year of age, underscore
the development of insulin resistance and hyperinsulinaemia as early features of the
mechanisms by which catch-up growth might confer increased risk for later diseases.
Whatever the neurohormonal mechanisms (or indeed the mechanisms for genetic
imprinting) that have been proposed to explain the roles of early nutrition and growth
pattern in susceptibility to later obesity and diseases, they are generally interpreted
alongside the teleological arguments of an early adaptive response for a ‘thrifty
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phenotype’ turned maladaptive later in life. Thus, according to the thrifty phenotype
hypothesis, originally put forward by Hales and Barker12, early pre- and postnatal
life is a critical period during which environmental exposures that hinder growth
will lead to the programming of thrifty mechanisms that is adaptive during the period
of limited supply of nutrients (or growth restraint), but which contribute to increased
risks for diseases during improved nutrition and catch-up growth later in life. But
which components of catch-up ‘growth’ serve as vehicle for driving the expression
of these imprinted thrifty mechanisms: catch-up in linear growth and height, catch-
up in lean tissue, or catch-up in body fat? In this context, there is now compelling ev-
idence that the dynamic process of catch-up growth per se is characterized by a dispro-
portionately higher rate of fat gain than lean tissue gain, i.e. by preferential ‘catch-up
fat’.30
THE INSULINO-RESISTANT ‘CATCH-UP FAT’ PHENOTYPE
This preferential catch-up fat phenotype, and its association with hyperinsulinaemia
and impaired glucose homeostasis, has been documented in infants and children
born SGA. In a study conducted in Switzerland31, reduced glucose oxidation and in-
creased lipid oxidation could indeed be observed in prepubertal non-diabetic children
born SGA. These impairments in substrate metabolism and in insulin sensitivity could
be attributed not only to their lower lean body mass but also to their higher body fat
content. More direct evidence for the occurrence of preferential catch-up fat early in
life can be derived from a recent longitudinal study of body composition – assessed by
dual energy x-ray absorptiometry (DEXA) scan – in infants between the ages of 2 and
5 years born SGA in Spain.32 A re-analysis of these data30 reveals that already between
ages of 2 and 4.5 years, children born SGA gained more total body fat and less lean
tissue, and hence a markedly higher ratio of fat mass to lean tissue mass, than children
born AGA, despite similar gains in weight and BMI (Figure 1). By about 4 years of age,
those children born SGA had greater total adiposity and abdominal fat, and showed
lower insulin sensitivity, than children born AGA.32 Another recent longitudinal
study33, using magnetic resonance imaging (MRI) to assess adipose tissue volume, in-
dicated that infants born SGA and showing complete catch-up in relation to head
growth and adiposity by 6 weeks after birth, still showed incomplete catch-up in length
and weight. There is also accumulating evidence that the phenomenon of preferential
catch-up fat also occurs during catch-up growth in infants born preterm: a population
group that has been reported to show reduced insulin sensitivity and compensatory
hyperinsulinaemia in childhood, adolescence and early adulthood.8–11 Indeed, the ap-
plication of whole-body magnetic resonance – which allows adipose tissue imaging
and its quantiﬁcation – has indicated that in infants born extremely preterm (<32
weeks gestational age) and profoundly deﬁcient in adipose tissue, the subsequent ac-
celerated postnatal growth was accompanied by accelerated fat gain such that, at their
expected time of delivery several weeks later, these preterm infants reached the same
total adiposity as term-born infants despite the fact that they were lighter and
shorter.34 Taken together, these studies further underscore the occurrence of
preferential catch-up fat, with lean tissue lagging behind in babies and infants showing
catch-up growth, and their predisposition to insulin resistance later in life.
These differences in body composition, associated with impaired glucose metabo-
lism, may persist into adulthood, as suggested by studies from Finland35 and from
England using DEXA scan36, indicating that for the same BMI as age-matched controls,
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healthy elderly individuals born SGA have 3–5 kg less lean tissue mass, more fat mass,
and a more central fat distribution. Similarly, studies from Denmark in cohorts of
healthy young men born SGA indicate that they have slightly less lean tissue mass
and slightlymore body fat, but clearly higher abdominal fatmass37 than age-matched con-
trols of similar BMI, or that they showed reduced forearm glucose uptake38 and reduced
muscle expression of key proteins involved in insulin signalling and glucose transport.39
Among explanations of how such non-optimal early growth followed by catch-up growth
could lead to these metabolic disorders, Eriksson40 recently underscored the potential
importance of impaired growth of organs and tissues that tracks into adulthood, with
poor liver growth predisposing them to hepatic insulin resistance and dyslipidaemia,
and poor muscle growth resulting in reduced buffering capacity for glucose disposal,
and hence predisposing them towards insulin resistance. Tappy41 has proposed a model
in which the metabolic disorders and impaired growth in these individuals born SGA are
secondary to growth hormone resistance. According to this model, the consequential
decrease in IGF-1 secretionwould lead to low growth rates and impaired glucosemetab-
olism, while the increase in body fat would lead to insulin resistance through increased
plasma FFAs.
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Figure 1. Longitudinal studies of human body composition demonstrating preferential catch-up fat in infants
born small for gestational age (SGA; n¼ 29) compared to controls born appropriate for gestational age
(AGA; n¼ 22). This ﬁgure is derived from a re-analysis of data on body weight and body composition
(lean body mass and %fat) assessed by dual energy x-ray absorptiometry (DEXA) scan in the study of Ibanez
et al 32 Note that (1) the velocity of fat gain (slope of fat mass versus age) is about twofold greater in the
infants born SGA than in controls born AGA, and that (2) the relatively constant ratio of fat mass to lean
tissue mass in infants born AGA contrasts sharply with the marked quasi-linear increase in this ratio in in-
fants born SGA over the 2-year period of body composition study.
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It is currently unknown whether these insulin-related impairments in people born
SGA precede or are preceded by preferential abdominal fat deposition, excess circu-
lating lipids or ectopic fat storage, all of which have been implicated in the develop-
ment of insulin resistance. Nonetheless, these studies in infants, children and adults
born SGA point to an early but long-lasting impairment in glucose homeostasis and
body composition that can be related to preferential catch-up fat during catch-up
growth. Of central importance to our understanding of the pathophysiology of
catch-up growth, therefore, is the question of whether (and how) processes that reg-
ulate fat storage speciﬁcally during catch-up fat may lead to a state of insulin resistance.
AUTOREGULATION OF FAT STORAGE DURING CATCH-UP FAT
In addressing this issue, it is important to emphasize that the phenomenon of prefer-
ential catch-up fat is not limited to individuals born SGA or to the growth phase. Such
increases in the ratio of fat mass to lean mass are also well documented in adults
recovering body weight after weight loss due to a variety of conditions, including
war-related famine, poverty-related under-nutrition, experimental starvation, anorexia
nervosa and other pathophysiological ‘hypermetabolic’ conditions such as cancer, sep-
tic shock and AIDS.42 Thus, a common denominator in many situations where there
are large decreases in body weight followed by weight recovery – whether during
growth or in adulthood – is that body fat is recovered at a disproportionately faster
rate than lean tissue. Since this phenomenon of preferential catch-up fat still occurs in
the absence of hyperphagia and on well-balanced diets, it underscores an elevated
metabolic efﬁciency for catch-up fat as a fundamental physiological reaction to growth
retardation.
Role of ‘adipose-speciﬁc’ suppression of thermogenesis
There is indeed converging evidence from experimental studies of prolonged starva-
tion and re-feeding in adult humans43–45 and in actively growing animals46–50 that an
elevated efﬁciency for catch-up fat is a phenomenon that occurs at all ages, and that
it is a carry-over effect of the suppression of thermogenesis (i.e. energy conservation
mechanisms) that occurred in the preceding period of food deprivation. This has been
referred to as adipose-speciﬁc control of thermogenesis51, that is, a control system that
has a slow time-constant by virtue of its response to signals arising only from the state
of depletion (or delayed expansion) of the body’s fat stores. In this autoregulatory
feedback system, signals from the depleted adipose fat stores exert a suppressive ef-
fect on thermogenesis. Support for the existence of a control system linking depletion
of fat stores and suppressed thermogenesis in humans comes from the re-analysis45,52
of longitudinal data on changes in basal metabolic rate (BMR) and in body composition
from the classic ‘Minnesota Experiment’ of semi-starvation and re-feeding.43 In this
study, 32 healthy men of normal body weight were subjected to 24 weeks of semi-
starvation (during which they lostw25% of initial body weight), followed by 12 weeks
of restricted re-feeding on diets relatively low in fat (w20% fat by energy). As shown
in Figure 2, there is a positive relationship between the deviation in body fat and the
change in adjusted BMR, an index of altered thermogenesis calculated from the change
in BMR after adjusting for losses of fat-free mass and fat mass. In other words, the
greater the degree of fat depletion during starvation, the greater the reduction in
adjusted BMR, and hence the greater the degree of suppressed thermogenesis. A
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similar relationship was also found after the 12-week period of restricted re-feeding,
i.e., the lower the degree of fat repletion, the greater the extent of reduction in re-
sidual BMR and hence the greater the degree of reduction in thermogenesis.52 Taken
together, the relationship between suppressed thermogenesis and fat depletion during
phases of both weight loss and weight recovery indicates the operation of a control
system with a negative feedback loop between thermogenesis and the state of deple-
tion of fat stores.
Although a similar type of evidence linking fat depletion (or delayed expansion of
the fat stores) and suppressed thermogenesis during catch-up growth in humans is
not available, direct evidence for an adipose-speciﬁc suppression of thermogenesis,
the role of which is to speciﬁcally accelerate body fat recovery, can be derived from
studies of complete energy balance in growing rats regaining weight after semi-starva-
tion (Figure 3). Under conditions whereby the rehabilitated animals were pair-fed to
weight-matched controls, the rate of protein deposition was found to be the same
as in controls, but that of fat deposition was increased by more than twofold. This
was shown to be the result of 10–15% lower energy expenditure during the ﬁrst
2–3 weeks of isocaloric refeeding.47,48,51 A number of factors that could theoretically
contribute to this difference in energy expenditure between re-fed and control animals
(age difference, physical activity, feeding pattern) have been evaluated and shown to
have a minimal impact on the difference in energy expenditure between the two
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Figure 2. Minnesota experiment of human starvation and re-feeding revisited: the relationship between
suppressed thermogenesis, assessed as change in basal metabolic rate (BMR) adjusted for changes in fat-
free mass and fat mass, and the state of depletion of body fat stores during weight loss (S12, week 12 of
semi-starvation) and weight recovery (R12, week 12 of restricted re-feeding). The relationship between
suppressed thermogenesis and fat depletion during phases of both weight loss and weight recovery suggests
the operation of a control system with a negative feedback loop between thermogenesis and the state of
depletion of fat stores. Adapted from Dulloo and Jacquet (1998, American Journal of Clinical Nutrition 68:
599–606) with permission.
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groups. Consequently, under these conditions of re-feeding, the lower energy expen-
diture in the re-fed animals is essentially a result of energy being spared due to sus-
tained suppression of thermogenesis for the purpose of catch-up fat. Taken
together, these ﬁndings in humans and in animals support the existence of an autore-
gulatory control system that participates in the regulation of catch-up growth by sus-
tained suppression of thermogenesis, and suggest that the energy thus conserved is
directed speciﬁcally for the recovery of fat mass rather than that of lean mass, i.e.
a thrifty metabolism speciﬁc for preferential catch-up fat.
THE THRIFTY METABOLISM THAT DRIVES CATCH-UP FAT: IMPACT
ON INSULIN AND LEPTIN SENSITIVITY
As skeletal muscle is an important site for energy conservation during starvation53–56,
the control system underlying this adipose-speciﬁc control of thermogenesis could op-
erate as a feedback loop between adipose tissue triglyceride stores and skeletal muscle
metabolism. As depicted in Figure 4, it could comprise a sensor(s) of the state of de-
pletion (or delayed expansion) of the fat stores, signal(s) dictating the suppression of
thermogenesis as a function of the state of depletion of the fat stores, and an effector
system mediating thermogenesis in skeletal muscle.57 At present, our understanding of
the components of this system is fragmentary. However, as skeletal muscle is the
major site for insulin-mediated glucose disposal, a reduction in the metabolic rate of
muscle would therefore result in a reduction in glucose utilization, leading to
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Figure 3. Sustained reduction in energy expenditure and accelerated fat deposition (catch-up fat) in a rat
model of semi-starvation/re-feeding, showing preferential catch-up fat driven by suppressed thermogenesis.
Changes in body composition and in energy balance were assessed over three successive periods of 10 days
in re-fed animals pair-fed to weight-matched (WM) controls. The lower energy expenditure during re-
feeding persists for 2–3 weeks, and is due almost entirely to a sustained suppression of thermogenesis
that drives catch-up fat during weight recovery. ** P< 0.01; *** P< 0.001 compared with WM controls.
Adapted from Dulloo and Jacquet (2001, International Journal of Obesity 25 (Suppl. 5): S22–S29) with
permission.
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hyperinsulinaemia. This in turn would serve to redirect the spared glucose towards de-
novo lipogenesis and fat storage in adipose tissue.
Muscle–adipose glucose redistribution
Support for this ‘glucose redistribution hypothesis’ can be derived from studies in
our animal model of catch-up fat driven solely by suppressed thermogenesis. These
have indicated that re-feeding on a low-fat diet resulted in a more pronounced
elevation in plasma insulin after a glucose load58, and that under conditions of hyper-
insulinaemic–euglycaemic clamps in vivo, insulin-stimulated glucose utilization in re-
fed animals is lower in skeletal muscle but higher in white adipose tissue59, thereby
suggesting a state of insulin resistance in skeletal muscle and insulin hyper-respon-
siveness in white adipose tissue. Furthermore, the fact that fatty acid synthase activ-
ity is higher in white adipose tissue from re-fed animals than from controls suggests
enhanced conversion of glucose to lipids in the adipose tissue fat stores.59 Of par-
ticular importance in these studies comparing re-fed and control animals is that this
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AMPK PI3K
Skeletal muscle
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Sign
al(s)?
Thermogenesis
SNS/thyroid
NE, T3
Leptin
Adiponectin
CRH/urocortins
+ +
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Figure 4. Schematic diagram depicting mechanisms by which the thrifty catch-up fat phenotype, driven by
the adipose-speciﬁc suppression of thermogenesis, may cross-link with early development of insulin and leptin
resistance. The model is built upon emerging evidence that an important thermogenic effector system in
skeletal muscle is mediated by substrate cycling between de novo lipogenesis and lipid oxidation61,62, and
it is orchestrated by phosphatidyloinositol 3-kinase (PI3K) and AMP-activated protein kinase (AMPK) under
the inﬂuence of insulin, leptin, adiponectin and perhaps other hormones (e.g. urocortins).61,62,66 These hor-
mones can interact to stimulate thermogenesis via the enhancement of AMPK and PI3K signalling either by
acting directly on skeletal muscle or centrally through the sympathetic (SNS)/thyroid axis via norepinephrine
(NE) and tri-iodothyronine (T3). By interfering with PI3K and/or AMPK signalling in skeletal muscle, the ac-
tions of the adipose-speciﬁc signal(s) that sense the state of depletion (or delayed expansion) of the adipose
tissue fat stores will suppress skeletal muscle thermogenesis, which during re-feeding will lead to concom-
itant insulin and leptin resistance. The resulting hyperinsulinaemia serves to redirect the glucose spared from
oxidation in skeletal muscle towards de novo lipogenesis and fat storage in white adipose tissue. CRH,
corticotropin releasing hormone.
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redistribution of glucose utilization away from skeletal muscle towards de-novo
lipogenesis and fat storage in adipose tissue can be demonstrated in the absence
of between-group differences in energy intake, lean tissue mass, total body fat
mass, regional fat distribution or in circulating free fatty acids. Similarly, the state
of insulin resistance in skeletal muscle of the re-fed animals cannot be attributed
to excess lipid storage in muscle cells, as histological staining of muscles revealed
that intramyocellular lipid content in muscles from re-fed animals was not higher
than in controls.59 Taken together, these data suggest that the muscle insulin resis-
tance and adipose tissue insulin hyper-responsiveness in the re-fed animals are not
related to overt lipotoxic stresses, but can be linked to the state of suppressed ther-
mogenesis per se. In other words, the mechanisms that lead to suppressed skeletal
muscle thermogenesis (in favour of catch-up fat) are interlinked with those that lead
to insulin resistance during catch-up growth. By what molecular mechanisms this
suppression of thermogenesis is brought about, and how these mechanisms of sup-
pressed thermogenesis might cross-link with early development of skeletal muscle
insulin resistance, are therefore fundamental issues that need to be addressed to
contribute to our understanding of how catch-up growth confers increased suscep-
tibility to insulin resistance and hyperinsulinaemia.
Molecular cross-links between suppressed thermogenesis and insulin
resistance
As the concentrations of key ‘adiposity’ hormones that might be implicated in the link
between glucose metabolism and thermogenesis in skeletal muscle (namely insulin and
leptin) are rapidly restored to control levels upon transition from starvation to re-
feeding58, our current working hypothesis is that the suppression of thermogenesis
and concomitant insulin resistance in skeletal muscle are brought about through the
inhibition of mechanisms by which these (and other) hormones interact to activate
thermogenesis in skeletal muscle.57 The nature of these postulated adipose-speciﬁc
signal(s) that inhibit thermogenesis in skeletal muscle are unknown, but there is
emerging evidence that their inhibitory actions on muscle thermogenesis could occur
through interference with the activation of two major signalling pathways in substrate
metabolism: phosphatidylinositol 3-kinase (PI3K) or AMP-activated protein kinase
(AMPK). Indeed, ex-vivo studies of microcalorimetry in intact skeletal muscle have
shown that PI3K and AMPK signalling – which are well known to inﬂuence insulin sen-
sitivity in this tissue – are both required for hormonal stimulation of muscle thermo-
genesis, since the direct thermogenic effects of leptin or corticotropin-releasing
hormone in skeletal muscle can be inhibited by selective inhibitors of either AMPK
or PI3K.60–62 On the basis of these ﬁndings, it follows that either diminished PI3K
and/or AMPK signalling in skeletal muscle could constitute impairments that are com-
mon to pathways that lead to both suppressed thermogenesis and to resistance to the
actions of insulin and leptin during catch-up growth (Figure 4). This notion is indeed
supported by recent data from our laboratory63 indicating diminished basal and insu-
lin-stimulated PI3K activity in skeletal muscle of rats showing catch-up fat driven by
suppressed thermogenesis during re-feeding on a low-fat diet, with additional impair-
ments in leptin-induced activation of AMPK during isocaloric re-feeding on diets high
in saturated fats.
Which molecular effectors of skeletal muscle thermogenesis might be under the
control of PI3K and AMPK signalling, and what factors contribute to such early
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impairments in these signalling pathways (i.e. impairments that precede excess adipos-
ity, circulating free fatty acids or intramyocellular lipids) are questions that have only
recently been the subject of investigation. Of particular interest is the demonstration
that rats showing catch-up fat due to suppressed thermogenesis also show diminished
mitochondrial mass and oxidative capacity speciﬁcally in the subsarcolemmal compart-
ment of skeletal muscle.64 Given the important role that subsarcolemmal mitochon-
dria have for bioenergetic support of signal transduction and substrate transport65,
the possibility arises that deﬁciency in this subpopulation of mitochondria could con-
tribute to impaired PI3K and AMPK signalling. While a reduction in the number of sub-
sarcolemmal mitochondria per se could contribute to the suppression of
thermogenesis that favours catch-up fat, impairments in PI3K or in AMPK could
also lead to a slowdown of a ‘futile’ substrate cycling between de-novo lipogenesis
and lipid oxidation. This thermogenic effector has recently been implicated in hor-
monal control of skeletal muscle thermogenesis, with PI3K being required in control-
ling the ﬂux of substrates through de-novo lipogenesis, and AMPK being required in
controlling the ﬂux of de-novo-synthesized fatty acids through mitochondrial
b-oxidation.61,62,66
Overall, therefore, there is emerging evidence for insulin and leptin resistance in
the early phase of catch-up fat, and for impairments in PI3K and AMPK signalling in
skeletal muscle in the mechanisms by which suppressed thermogenesis might cross-
link with insulin and leptin resistance during catch-up growth. Consequently, impair-
ments in these signalling pathways in skeletal muscle may constitute the molecular
basis by which the thrifty metabolism (suppressed thermogenesis) that accelerates
fat recovery confers enhanced susceptibility to the development of insulin resistance
and hyperinsulinaemia during catch-up growth.
THRIFTY METABOLISM DRIVING CATCH-UP FAT: ADAPTIVE
TURNED MALADAPTIVE
Thebiological signiﬁcanceof this thriftymetabolismunderlying catch-up fat – characterized
by concurrent hyperinsulinaemia, skeletal muscle insulin and leptin resistance, and
adipose tissue insulin hyper-responsiveness – would be to achieve both blood glu-
cose homeostasis and the rapid replenishment of the fat stores by diverting glucose
spared from oxidation in skeletal muscle to lipogenesis and fat storage in adipose
tissue. Under conditions of intermittent periods of food availability that prevailed
during much of mammalian evolution, this coordinated redistribution of glucose
from muscle to adipose tissue probably had survival value since it enables the rapid
replenishment of fat stores, and hence rapid restoration of survival capacity, without
compromising blood glucose homeostasis. Despite its ‘adaptive’ nature within the
context of a lifestyle of famine-and-feast, this state may have deleterious conse-
quences in the context of the modern lifestyle, characterized by low physical activity
and energy-dense diets rich in fat and reﬁned carbohydrates. In fact, a shift in diet
from complex carbohydrates to animal fat and reﬁned carbohydrates leads to an
exacerbated suppression of thermogenesis, a more pronounced state of hyperinsu-
linaemia, hyperglycaemia and excess adiposity in animals recovering weight, com-
pared with fed controls growing spontaneously on isocaloric amounts of the same
high-fat diet.58 As depicted in Table 1, high levels of (saturated) fat in the diet,
even in the absence of hyperphagia, has compromised a complex homeostatic
system.
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To what extent this disruption of glycaemia resides in an exacerbated state of skel-
etal-muscle insulin resistance and/or in the inability of adipose tissue to dispose of ex-
cess glucose spared as a result of an exacerbated suppression of thermogenesis during
high-fat re-feeding is currently under investigation. Whatever the answers to these
questions, however, it is clear that as the phase of catch-up growth may last for several
months to several years in humans7, the drive to suppressed thermogenesis for the
purpose of sparing glucose for catch-up fat, via its orchestration through insulin and
leptin resistance in skeletal muscle together with altered insulin responsiveness in ad-
ipose tissue, constitute a thrifty phenotype that predisposes individuals with catch-up
growth to insulin and leptin resistance and risks for later metabolic syndrome.
Could such thrifty energy metabolism in humans be programmed or imprinted ear-
lier in fetal or neonatal life, and hence long-lasting so as to operate beyond the phase
of catch-up growth? The answer to this question seems plausible in the light of recent
evidence, depicted in Figure 5, indicating a lower resting energy expenditure (even af-
ter adjustments for weight, height, or lean tissue mass) in a group of elderly adults with
low birth weight and showing a twofold greater prevalence of metabolic syndrome
than in those with a high birth weight.67 In the complex interactions between the
genetic constitution of the individual, programming or imprinting early in life, and a sub-
sequent lifestyle of energy-dense foods and low physical activity, the thrifty ‘catch-up fat’
phenotype – which evolved to increase survival capacity in a hunter–gatherer lifestyle of
periodic food shortages – could thus be a central event in growth trajectories to obe-
sity and to diseases that cluster into the insulin resistance (metabolic) syndrome. Thus,
the mechanisms by which body fat is acquired during early growth would seem to be at
least as important as the consequences of excess fat per se in the pathogenesis of
type-2 diabetes and cardiovascular diseases.
SUMMARY
Epidemiological and clinical studies have suggested that neonates, infants and children
who show catch-up growth are predisposed to obesity, type-2 diabetes and cardiovas-
cular diseases later in life. The pathophysiological mechanisms by which catch-up
growth confer increased risks for these diseases are obscure, but there is compelling
Table 1. Role of suppressed thermogenesis in susceptibility to hyperinsulinaemia and glucose intoler-
ance during catch-up fat in rats summarized from reference.58
Isocaloric re-feeding after semi-starvation
Low-fat diet
(RF-LF versus C-LF)
High-fat diet
(RF-HF versus C-HF)
Thermogenesis Y YY
Rate of body fat gain [ [[
Plasma leptin [ [[
Plasma insulin [ [[
Glucose tolerance Normal (euglycaemic) Impaired (hyperglycaemic)
RF-LF versus C-LF, re-fed animals on low-fat diet versus control animals on isocaloric low-fat diet; RF-HF
versus C-HF: re-fed animals on high-fat diet versus control animals on isocaloric high-fat diet; Y,
suppressed; YY, further suppressed; [, elevated; [[, further elevated.
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evidence that the dynamic process of catch-up growth per se is characterized by in-
sulin resistance and by a disproportionately higher rate in recovering body fat than
lean tissue (i.e. preferential ‘catch-up fat’). This chapter ﬁrst focuses upon this prefer-
ential ‘catch-up fat’ phenotype as a risk factor for obesity and insulin-related compli-
cations in infants and children who experienced catch-up growth after earlier fetal
or neonatal growth retardation, or after preterm birth. It subsequently reviews the
evidence indicating that such preferential catch-up fat is primarily driven by energy
conservation (thrifty) mechanisms operating via suppressed thermogenesis, with glu-
cose thus spared from oxidation in skeletal muscle being directed towards de novo
lipogenesis and storage in adipose tissue. A molecular-physiological framework is pre-
sented which integrates emerging insights into the mechanisms by which this thrifty
‘catch-up fat’ phenotype cross-links with early development of insulin and leptin resis-
tance. In the complex interactions between the genetic constitution of the individual,
programming earlier in life, and a subsequent lifestyle of energy-dense foods and low
physical activity, this thrifty ‘catch-up fat’ phenotype – which probably evolved to increase
survival capacity in a hunter–gatherer lifestyle of periodic food shortages – is a central
event in growth trajectories to obesity and the insulin resistance (metabolic)
syndrome.
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Figure 5. Extent of suppressed thermogenesis (thrifty energy metabolism) in the compartments of resting
energy expenditure (REE) in young men or rats showing preferential catch-up fat after semi-starvation, as
well as in weight-stable healthy elderly men with low birth weight. The reduction in adjusted REE is relative
to control values set at 100% (dotted line). The following should be noted. (1) The value for extent of sup-
pressed thermogenesis (as % of baseline basal metabolic rate) in healthy young men recovering body weight
after semi-starvation is derived from the Minnesota Experiment of Keys et al43, and was determined in a re-
analysis of the data on their basal metabolic rate after adjustments for changes in fat-free mass and in fat mass
relative to pre-starvation values.52 (2) In rats showing catch-up growth after post-weaning semi-starvation,
REE is taken as their total energy expenditure (essentially sedentary) relative to that of weight-matched con-
trols consuming the same amount of energy and gaining protein mass at the same rate, whether during
re-feeding on a low-fat diet or on an isocaloric diet rich in animal saturated fat.47,48,58 (3) In the group of
healthy elderly men with low birth weight relative to another group with high birth weight, REE was deter-
mined from measurements of both preprandial and postprandial REE adjusted for body weight and height; in
this study by Kensara et al, the adjustments of REE for fat-free mass, muscle mass, non-muscular (fat-free soft
tissue) mass, or for the ratio of muscle to non-muscle (fat-free soft tissue) mass also yielded lower REE
values (by 8–12%) in the low-birth-weight group than in the high-birth-weight group.
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